GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lipidor AB (OSTO:LIPI) » Definitions » Ending Cash Position

Lipidor AB (OSTO:LIPI) Ending Cash Position : kr0.00 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Lipidor AB Ending Cash Position?

Lipidor AB's Ending Cash Position for the quarter that ended in Dec. 2024 was kr0.00 Mil.

Lipidor AB's quarterly Ending Cash Position increased from Mar. 2024 (kr0.34 Mil) to Jun. 2024 (kr22.75 Mil) but then declined from Jun. 2024 (kr22.75 Mil) to Dec. 2024 (kr0.00 Mil).

Lipidor AB's annual Ending Cash Position declined from Dec. 2022 (kr8.93 Mil) to Dec. 2023 (kr0.63 Mil) but then increased from Dec. 2023 (kr0.63 Mil) to Dec. 2024 (kr10.22 Mil).


Lipidor AB Ending Cash Position Historical Data

The historical data trend for Lipidor AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipidor AB Ending Cash Position Chart

Lipidor AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 64.30 51.31 8.93 0.63 10.22

Lipidor AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.82 0.63 0.34 22.75 -

Lipidor AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Lipidor AB's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.628+9.587
=10.22

Lipidor AB's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00


Lipidor AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Lipidor AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipidor AB Business Description

Traded in Other Exchanges
N/A
Address
c/o Ekonomistubben AB, Box 55931, Stockholm, SWE, 102 16
Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.

Lipidor AB Headlines

No Headlines